logo
Select company
Select metric
$ 245.01MNet Cash Flow - Operations
VS
Market
69
Sector
88
Industry
97
History
100
$ 14.26Close
$ 8.21 - $ 14.6 52-Week Range
Ticker Information

Ticker

TBPH

Company Name

THERAVANCE BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

THERAVANCE BIOPHARMA INC - Net Cash Flow - Operations Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TBPH - CF - Operations Historical data
DateNet Cash Flow - Operations
6/30/2025$ 245.01M
3/31/2025$ 32.53M
12/31/2024$ -11.54M
9/30/2024$ -11.49M
6/30/2024$ -8.78M
3/31/2024$ -16.8M
12/31/2023$ -27M
9/30/2023$ -150.2M
6/30/2023$ -169.85M
3/31/2023$ -172.14M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • THERAVANCE BIOPHARMA INC's latest trailing twelve months (TTM) CF - Operations stands at $ -249.83M.
  • Over the past 5 years, THERAVANCE BIOPHARMA INC's average CF - Operations has been $ -117.04M.
  • The median CF - Operations for THERAVANCE BIOPHARMA INC during this period was $ -157.13M
  • THERAVANCE BIOPHARMA INC reached its highest CF - Operations over the past 5 years at $ 245.01M.
  • The lowest CF - Operations recorded by THERAVANCE BIOPHARMA INC in the same timeframe $ -265.17M

THERAVANCE BIOPHARMA INC's CF - Operations vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Operations Benchmarks
CompanyCF - Operations
SAGE : SAGE THERAPEUTICS INC $ -289.34MKURA : KURA ONCOLOGY INC $ 124.99MZVRA : ZEVRA THERAPEUTICS INC $ -46.21MNKTR : NEKTAR THERAPEUTICS $ -184.91MGYRE : GYRE THERAPEUTICS INC $ 927KNRIX : NURIX THERAPEUTICS INC $ -230.38MEYPT : EYEPOINT PHARMACEUTICALS INC $ -190.59MSNDX : SYNDAX PHARMACEUTICALS INC $ -302.67MADCT : ADC THERAPEUTICS SA $ -127.32MYMAB : Y-MABS THERAPEUTICS INC $ -17.8M

Similar metrics to CF - Operations:

Definition of Net Cash Flow - Operations

[Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.

TBPH - Net Cash Flow - Operations, Last 5 years

$ -265.17M

Minimum

Mar 31, 2021

$ 245.01M

Maximum

Jun 30, 2025

$ -117.04M

Average

$ -157.13M

Median

CF - Operations Benchmark Analysis

 The chart above depicts the distribution of CF - Operations for companies in the Total Stock Market. The average CF - Operations of the companies is $ 57.94M with a standard deviation of $ 141.66M.
The following table provides additional summary stats:
CF - Operations in the Market:
filtered constituents3.27K
min$ -406M
max$ 506.5M
average$ 57.94M
median$ 10.78M
std$ 141.66M